MedPath

Diagnosing Minimal Hepatic Encephalopathy

Conditions
Hepatic Encephalopathy
Liver Cirrhosis
Interventions
Diagnostic Test: Simultaneous EEG and CRT
Registration Number
NCT05433948
Lead Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Brief Summary

Our purpose is to

1. Examine the correlation between MDF in a resting EEG, recorded just before the CRT test, and the variance in reaction times indicated by the CRT index

2. At simultaneous CRT and EEG recording, examine whether a change in EEG is seen immediately before an extended reaction time occurs (defined by the 75th percentile). This will shed light on a direct pathophysiological association between what is measured with EEG and CRT.

3. Investigate whether cyclicity can be detected in the continuous reaction times and if so, whether amplitude and wavelength in this cyclic activity are correlated to EEG parameters.

4. Examine whether a response to standard HE treatment can be detected with EEG in patients who are thought to suffer from it. As well as if baseline outcome predict future hepatic encephalopathy.

5. With a view to further validating our findings, investigators want to correlate results from EEG and CRT with the most internationally widespread psychometric test, the Portosystemic Encephalopathy test (PSE), which necessitates the establishment of Danish normal values. A secondary purpose of this study is therefore

6. To establish Danish normal values for the PSE test and the Animal Naming test in Danes

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
550
Inclusion Criteria

Not provided

Exclusion Criteria
  1. Organic brain disease (eg previous epilepsy, apoplexy, dementia)
  2. Hyponatraemia (Na <124 mmol / L)
  3. Sepsis one week prior to tests.
  4. Heart failure (EC less than 30% or NYHA class III and IV)
  5. Severe chronic obstructive pulmonary disease (GOLD stage 3 and 4 ie FEV1 / FVC below 0.7 and FEV1 <50% of expected value)
  6. Highly controllable diabetes (HbA1C> 60 mmol / mol)
  7. Renal failure (eGFR below 60)
  8. Known neurological diseases (epilepsy, stroke, dementia)
  9. Intake of coffee or alcohol 6 hours before tests and change of dose in psychoactive drugs within 6 days of the test (morphine, antipsychotics, antidepressants) -

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Liver cirrhosis with normal cognitionSimultaneous EEG and CRTLiver cirrhosis and performs normally in all psychometric tests. n=100
Liver cirrhosis with minimal hepatic encephalopathySimultaneous EEG and CRTLiver cirrhosis and performs abnormally en 2 or more psychometric test. n=100
Liver cirrhosis and overt hepatic encephalopathySimultaneous EEG and CRTWest Haven grade 2 or more. n=50
Healthy control personsSimultaneous EEG and CRTCompletely healthy persons, age, and gender-matched to cirrhosis patients. n=100
Primary Outcome Measures
NameTimeMethod
Change in EEG spectral and frequency analysis with a clinically indicated standard treatment for minimal hepatic encephalopathyUp to 60 months

Some patients will be found eligible for treatment with lactulose or rifaximin due to signs of minimal hepatic encephalopathy. Investigators will use EEG relative theta and delta activity to measure the efficacy of the treatment.

Concordant changes in reaction times and in EEG spectral and frequency analysisUp to 60 months

During CRT 150 reaction times are measured. Investigators want to measure if prolonged reaction times \>75 percentile are preceded by spectral and frequency changes in EEG. For EEG investigators will assess relative theta and delta activity. EEG and CRT will be done simultaneously.

Observation of cyclic activity in continous reaction times (CRT measures)Up to 60 months

Apply mathematically modeled time analysis to establish cyclicity in the 150 measures reaction times and examine if cyclic activity correlates to relative theta and delta activity in the EEG.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital of South West Jutland

🇩🇰

Esbjerg, Denmark

© Copyright 2025. All Rights Reserved by MedPath